MAFLD

This study looks at whether oral semaglutide, a drug already used for diabetes, can slow down kidney disease in people who also have fatty liver disease. About 90 adults with both conditions will receive either standard care plus semaglutide or standard care alone for two years. …

This study looks at whether taking probiotics (good bacteria) along with doing resistance exercise can help people with fatty liver disease. The goal is to see if this combination reduces liver fat and improves health. The study will involve 180 adults aged 18-60 who have been di…

This study tests whether diacerein, a drug made from a compound found in rhubarb, can help treat metabolic fatty liver disease (MAFLD) in adults. About 74 people will receive either the drug or a placebo to see if it safely reduces liver fat and improves liver function. The goal …

This study is testing whether adding a third diabetes drug (alogliptin) to a standard two-drug combination (pioglitazone and metformin) works better for people who have both type 2 diabetes and fatty liver disease. Researchers will enroll 80 participants to see if the three-drug …

This study will test a new handheld device that measures liver stiffness and fat, comparing it to a standard machine. About 224 adults with chronic hepatitis B or fatty liver disease will have both scans while lying down and sitting. The goal is to see if the handheld device is a…